Marleen Tordoir

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process

Jan Spanholtz, Frank Preijers, Marleen Tordoir et al. · PLoS ONE · 2011 · 238 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

Harry Dolstra, Mieke W.H. Roeven, Jan Spanholtz et al. · Clinical Cancer Research · 2017 · 211 citations

Medicine, Hematology, Immunology +17

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy

Jan Spanholtz, Marleen Tordoir, Diana Eissens et al. · PLoS ONE · 2010 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice

Jeannette Cany, Anniek B. van der Waart, Marleen Tordoir et al. · PLoS ONE · 2013 · 90 citations · Full text

Life Sciences, Hematology, Immunology +17

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

John P. Veluchamy, Jan Spanholtz, Marleen Tordoir et al. · PLoS ONE · 2016 · 85 citations · Full text

Life Sciences, Immunology, Oncology +17